ImmunityBio Inc. Common Stock vs James Hardie Industries plc. Ordinary Shares — how do they compare? ImmunityBio Inc. Common Stock trades at $10.53 (market cap $10.51B), while James Hardie Industries plc. Ordinary Shares trades at $25.06 (market cap $14.60B). The key difference: James Hardie Industries plc. Ordinary Shares is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, James Hardie Industries plc. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and James Hardie Industries plc. Ordinary Shares for 1 Days on average.
| IBRX | JHX | |
|---|---|---|
Market Cap | $10.51B | $14.60B |
Volume | 10,445,785 | 7,262,924 |
Sector | Health | Basic Materials |
52-Week High | $11.55 | $31.08 |
52-Week Low | $1.98 | $16.69 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $10.97B | $18.83B |
Trailing returns across standard periods
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →James Hardie manufactures fiber cement products for residential and commercial construction. Its portfolio includes exterior siding, interior boards, and other building materials.
Read more on JHX →